These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 1424203
1. Point mutations detected in the androgen receptor gene of three men with partial androgen insensitivity syndrome. Saunders PT, Padayachi T, Tincello DG, Shalet SM, Wu FC. Clin Endocrinol (Oxf); 1992 Sep; 37(3):214-20. PubMed ID: 1424203 [Abstract] [Full Text] [Related]
2. Human androgen insensitivity due to point mutations encoding amino acid substitutions in the androgen receptor steroid-binding domain. Murono K, Mendonca BB, Arnhold IJ, Rigon AC, Migeon CJ, Brown TR. Hum Mutat; 1995 Sep; 6(2):152-62. PubMed ID: 7581399 [Abstract] [Full Text] [Related]
3. Correlation of clinical, endocrine and molecular abnormalities with in vivo responses to high-dose testosterone in patients with partial androgen insensitivity syndrome. Tincello DG, Saunders PT, Hodgins MB, Simpson NB, Edwards CR, Hargreaves TB, Wu FC. Clin Endocrinol (Oxf); 1997 Apr; 46(4):497-506. PubMed ID: 9196614 [Abstract] [Full Text] [Related]
5. Point mutation in the steroid-binding domain of the androgen receptor gene in a family with complete androgen insensitivity syndrome (CAIS). Jakubiczka S, Werder EA, Wieacker P. Hum Genet; 1992 Nov; 90(3):311-2. PubMed ID: 1487249 [Abstract] [Full Text] [Related]
13. Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS. Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9534-8. PubMed ID: 2594783 [Abstract] [Full Text] [Related]
14. Substitution of valine-865 by methionine or leucine in the human androgen receptor causes complete or partial androgen insensitivity, respectively with distinct androgen receptor phenotypes. Kazemi-Esfarjani P, Beitel LK, Trifiro M, Kaufman M, Rennie P, Sheppard P, Matusik R, Pinsky L. Mol Endocrinol; 1993 Jan; 7(1):37-46. PubMed ID: 8446106 [Abstract] [Full Text] [Related]
15. Single amino acid substitution (840Arg-->His) in the hormone-binding domain of the androgen receptor leads to incomplete androgen insensitivity syndrome associated with a thermolabile androgen receptor. Imasaki K, Hasegawa T, Okabe T, Sakai Y, Haji M, Takayanagi R, Nawata H. Eur J Endocrinol; 1994 Jun; 130(6):569-74. PubMed ID: 8205256 [Abstract] [Full Text] [Related]
16. Complete androgen insensitivity syndrome caused by the R855H mutation in the androgen receptor gene. Skordis N, Lumbroso S, Perikleous M, Sismani C, Patsalis PC, Sultan C. J Pediatr Endocrinol Metab; 2005 Mar; 18(3):309-13. PubMed ID: 15813610 [Abstract] [Full Text] [Related]
17. Clinical, cytogenetic and molecular analysis of androgen insensitivity syndromes from south Indian cohort and detection and in-silico characterization of androgen receptor gene mutations. V G A, S R, K M M, K T, S A, S N, A MP, J M, D A. Clin Chim Acta; 2016 Jan 30; 453():123-30. PubMed ID: 26688387 [Abstract] [Full Text] [Related]
19. Androgen receptor gene mutation associated with complete androgen insensitivity syndrome and Sertoli cell adenoma. Ko HM, Chung JH, Lee JH, Jung IS, Choi IS, Juhng SW, Choi C. Int J Gynecol Pathol; 2001 Apr 30; 20(2):196-9. PubMed ID: 11293168 [Abstract] [Full Text] [Related]
20. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity. Peters I, Weidemann W, Romalo G, Knorr D, Schweikert HU, Spindler KD. Mol Cell Endocrinol; 1999 Feb 25; 148(1-2):47-53. PubMed ID: 10221770 [Abstract] [Full Text] [Related] Page: [Next] [New Search]